Determining whether Tempus AI represents a favorable purchase or sale depends entirely on an individual investor's portfolio strategy, risk tolerance, and perspective on artificial intelligence applications in healthcare. Proponents highlight its rapid revenue growth, proprietary clinical database, and market leadership in precision oncology as strong reasons to buy. Conversely, cautious analysts emphasize high valuation volatility and profitability timelines, making independent research essential.